Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Correction

Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

Authors: Filippo Lococo, Luca Boldrini, Charles-Davies Diepriye, Jessica Evangelista, Camilla Nero, Sara Flamini, Angelo Minucci, Elisa De Paolis, Emanuele Vita, Alfredo Cesario, Salvatore Annunziata, Maria Lucia Calcagni, Marco Chiappetta, Alessandra Cancellieri, Anna Rita Larici, Giuseppe Cicchetti, Esther G. C. Troost, Róza Ádány, Núria Farré, Ece Öztürk, Dominique Van Doorne, Fausto Leoncini, Andrea Urbani, Rocco Trisolini, Emilio Bria, Alessandro Giordano, Guido Rindi, Evis Sala, Giampaolo Tortora, Vincenzo Valentini, Stefania Boccia, Stefano Margaritora, Giovanni Scambia

Published in: BMC Cancer | Issue 1/2023

Login to get access

Excerpt

Correction: BMC Cancer 23, 540 (2023)
Metadata
Title
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study
Authors
Filippo Lococo
Luca Boldrini
Charles-Davies Diepriye
Jessica Evangelista
Camilla Nero
Sara Flamini
Angelo Minucci
Elisa De Paolis
Emanuele Vita
Alfredo Cesario
Salvatore Annunziata
Maria Lucia Calcagni
Marco Chiappetta
Alessandra Cancellieri
Anna Rita Larici
Giuseppe Cicchetti
Esther G. C. Troost
Róza Ádány
Núria Farré
Ece Öztürk
Dominique Van Doorne
Fausto Leoncini
Andrea Urbani
Rocco Trisolini
Emilio Bria
Alessandro Giordano
Guido Rindi
Evis Sala
Giampaolo Tortora
Vincenzo Valentini
Stefania Boccia
Stefano Margaritora
Giovanni Scambia
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11606-7

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine